AIM Step 10
4th Year MBBS
Endocrine + Reproduction
4th Year MBBS
Endocrine + Reproduction
Student Memory Support
Topic 16 — Gynecologic Malignancies: Cervical, Endometrial and Ovarian Cancer
High-yield memory reinforcement for rapid KMU-focused revision of pathology, prevention, diagnosis, staging and management principles.
1. High-Yield Flashcards
Tap each question to reveal the answer.
Which persistent infection is the major initiating factor in cervical carcinoma?
Persistent infection with high-risk HPV, especially oncogenic types such as 16 and 18.
Which tumor-suppressor pathways are disrupted by high-risk HPV E6 and E7?
E6 interferes with p53, while E7 interferes with the RB pathway.
What is the characteristic microscopic appearance of cervical squamous cell carcinoma?
Invasive nests or cords of malignant squamous cells, sometimes with keratin pearls and intercellular bridges.
Which symptom should strongly raise suspicion of cervical carcinoma?
Postcoital or otherwise abnormal vaginal bleeding, especially with a friable cervical lesion.
What is the definitive method for confirming suspected invasive cervical carcinoma?
Histological examination of a cervical biopsy.
Which lesion is the important precursor of many endometrioid endometrial carcinomas?
Atypical endometrial hyperplasia, also termed endometrial intraepithelial neoplasia (EIN).
Which hormonal pattern promotes endometrial hyperplasia and endometrioid carcinoma?
Prolonged estrogen stimulation without adequate progesterone opposition.
Which clinical presentation is particularly important in endometrial carcinoma?
Postmenopausal bleeding or other abnormal uterine bleeding.
Which aggressive endometrial carcinoma is associated with atrophic endometrium and TP53 abnormalities?
Serous endometrial carcinoma.
Which four broad categories are used to classify ovarian tumors?
Epithelial, germ-cell, sex-cord stromal and metastatic tumors.
Which precursor site is linked to many high-grade serous tubo-ovarian carcinomas?
The distal fallopian tube, particularly serous tubal intraepithelial carcinoma.
What is the characteristic route of spread of epithelial ovarian carcinoma?
Transcoelomic spread across peritoneal surfaces, commonly involving the omentum.
Which serum marker is commonly associated with epithelial ovarian carcinoma?
CA-125, although it is not specific enough to establish the diagnosis by itself.
Which serum marker is associated with an ovarian yolk-sac tumor?
Alpha-fetoprotein (AFP).
Which serum marker is useful in granulosa-cell tumors?
Inhibin.
What treatment combination is central when chemotherapy is indicated for epithelial ovarian carcinoma?
Platinum-based chemotherapy commonly combined with a taxane.
2. Mnemonics
Mnemonic Title: Cervical Cancer Prevention
VST
Meaning: Vaccination → Screening → Treatment of precursor lesions.
Mnemonic Title: Ovarian Tumor Categories
EGSM
Meaning: Epithelial → Germ-cell → Sex-cord stromal → Metastatic.
Mnemonic Title: Ovarian Tumor Markers
CALBI
Meaning: CA-125 → epithelial; AFP → yolk sac; LDH → dysgerminoma; β-hCG → choriocarcinomatous tumors; Inhibin → granulosa-cell tumor.
3. Memory Tables
Cervical vs Endometrial vs Ovarian Carcinoma
| Feature | Cervical | Endometrial | Ovarian |
|---|---|---|---|
| Major association | Persistent high-risk HPV | Unopposed estrogen/EIN pathway | Tumor-type specific pathways |
| Typical clue | Postcoital bleeding | Postmenopausal bleeding | Bloating, early satiety, ascites |
| Definitive diagnosis | Cervical biopsy | Endometrial sampling | Histopathology |
| Important spread | Local pelvic and nodal spread | Myometrial/lymphatic spread | Transcoelomic peritoneal spread |
Selected Ovarian Tumors and Markers
| Tumor | Category | Useful Marker/Clue |
|---|---|---|
| Epithelial carcinoma | Epithelial | CA-125 |
| Yolk-sac tumor | Germ-cell | AFP |
| Dysgerminoma | Germ-cell | LDH |
| Granulosa-cell tumor | Sex-cord stromal | Inhibin |
4. Rapid Revision Points — Last-Minute Revision
Must Remember:
- Persistent high-risk HPV is central to cervical carcinogenesis.
- E6 affects p53; E7 affects RB.
- A visible suspicious cervical lesion requires biopsy for diagnosis.
- HPV vaccination provides primary prevention; screening detects precursor disease.
- Unopposed estrogen promotes endometrial hyperplasia and endometrioid carcinoma.
- Atypical hyperplasia/EIN carries substantially greater malignant potential than hyperplasia without atypia.
- Postmenopausal bleeding requires assessment for endometrial pathology.
- Epithelial ovarian carcinoma commonly spreads across the peritoneal cavity.
- CA-125 supports assessment but does not independently prove ovarian malignancy.
- Increasing anatomical stage generally indicates greater spread and poorer prognosis.
KMU Exam Trap: Screening tests such as cervical cytology are designed to detect precursor disease; a clinically suspicious invasive lesion still requires tissue diagnosis.
5. Clinical Memory Hooks
Friable cervical mass with contact bleeding → suspect invasive cervical carcinoma → confirm with biopsy.
Obesity + chronic anovulation + abnormal uterine bleeding → prolonged estrogenic stimulation → endometrial hyperplasia/endometrioid pathway.
Postmenopausal bleeding → investigate endometrium → tissue sampling confirms or excludes malignancy.
Bloating + early satiety + complex adnexal mass + ascites → suspect ovarian malignancy → imaging, markers and histopathology guide evaluation.
6. Starred High-Yield Exam Points
- ⭐ Persistent high-risk HPV → E6/p53 and E7/RB disruption → cervical precursor lesions and invasive carcinoma.
- ⭐ Cervical screening detects preinvasive disease; biopsy confirms suspected invasive carcinoma.
- ⭐ Unopposed estrogen → atypical hyperplasia/EIN → increased risk of endometrioid endometrial carcinoma.
- ⭐ Postmenopausal bleeding is a key clinical signal requiring endometrial evaluation.
- ⭐ High-grade serous ovarian carcinoma may arise from distal fallopian-tube precursor lesions.
- ⭐ Ovarian carcinoma spreads characteristically by transcoelomic dissemination to peritoneum and omentum.
- ⭐ CA-125 is useful in epithelial ovarian cancer assessment and follow-up but is not a stand-alone diagnostic test.